Search is Powered by Google
Breast Cancer News

Many Child Tumours Indicate Increased Maternal Breast Cancer Risk

Main Category: Breast Cancer
Also Included In: Cancer / Oncology
Article Date: 21 Jan 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.4 (5 votes)

Health Professional:4 and a half stars

4.4 (5 votes)

Article Opinions: 0 posts

Scientists at the University of Manchester have found links between many types of childhood cancer and increased breast cancer risk in the mother.

Although a previous study found high risk of breast cancer in mothers of children with soft tissue sarcomas, breast cancer risks in mothers of other childhood cancers remain largely unknown and the reasons for the links are not fully understood.

The study, to be published in ecancermedicalscience, explored the subject by varying the type of childhood solid cancer, and found that for other cancers such as skin and cancer of the central nervous system, the established relationship stood.

The research reviewed the long term incidence of breast cancer in mothers of 2668 children with solid tumours included in the Manchester Children's Tumour Registry, 1954-1996. The subjects were traced and followed up to the 31st of December 2000 using the UK National Health Service Central Register.

The number of observed cases was compared to the number of expected (normal) cases for women of the age range covered in the UK.

The results showed that the excess risk of breast cancer among mothers of children with solid tumours is not uniform across all groups, but is associated with a small number of tumour types and patient characteristics.

Excesses of breast cancer were found most frequently in mothers of children with rhabdomyosarcoma (RMS) - a cancer of the connective tissues, in which the cancer cells are thought to arise from skeletal muscle progenitors. Solid tumours of the skin and central nervous system in the index child were also found to be stronger indicators of maternal breast cancer.

The study confirms and extends the previous findings of a temporal relationship between embryonal RMS in children and breast cancer in their mothers and points to pregnancy as the critical period, when mothers and children are physiologically linked.

The research team, led by Dr Dong Pang, suggest that the increased cancer risk relationships may be due to germline mutations to cancer associated genes, either inherited or new in the offspring. They hypothesise that these germline mutations might commonly target the p53 pathway affecting tissue remodelling in the foetal adrenal cortex, not just one single gene within that pathway. They infer that the pathway may be disrupted by a germline mutation within the TP53 gene itself, as well as other genes p14ARF, BRCA1 and BRCA2, etc.

It is thought that this mechanism may also be operating in mothers of children with other types of cancers.

http://www.ecancermedicalscience.com




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
18 Jul 2008
A large study published in The Lancet Oncology has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...